Sun Pharmaceutical Industries Limited (sunpharma) – Financial And Strategic Swot Analysis Review
July, 26, 2014 : Company Profiles and Conferences presents a Company Report on “Sun Pharmaceutical Industries Limited (SUNPHARMA) – Financial and Strategic SWOT Analysis Review”, who helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
Sun Pharmaceutical Industries Limited (SUNPHARMA) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the companys businesses and operations. The profile is bring to you a clear and an unbiased view of the companys key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
– Business description A detailed description of the companys operations and business divisions.
– Corporate strategy Analysts summarization of the companys business strategy.
– SWOT Analysis A detailed analysis of the companys strengths, weakness, opportunities and threats.
– Company history Progression of key events associated with the company.
– Major products and services A list of major products, services and brands of the company.
– Key competitors A list of key competitors to the company.
– Key employees A list of the key executives of the company.
– Executive biographies A brief summary of the executives employment history.
– Key operational heads A list of personnel heading key departments/functions.
– Important locations and subsidiaries A list and contact details of key locations and subsidiaries of the company.
– Key manufacturing facilities A list of key manufacturing facilities of the company.
– Detailed financial ratios for the past five years The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
– Interim ratios for the last five interim periods The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Sun Pharmaceutical Industries Limited (Sun Pharma) is an integrated specialty pharmaceutical company. It manufactures and markets wide range of pharmaceutical formulations as branded generics and generic pharmaceuticals in various therapeutic areas including psychiatry, neurology, cardiology, nephrology, gastroenterology, orthopedics and ophthalmology. The company carries out product development, process chemistry, and manufacturing of complex active pharmaceutical ingredients (APIs), and dosage forms. The company broadly classified its products into two categories, namely, Formulations and Active Pharmaceutical Ingredients (APIs).
Sun Pharmaceutical Industries Limited Key Recent Developments
May 02, 2014 Sun Pharma announces manufacturing consolidation
Apr 30, 2014 AP High Court Puts Sun PharmaRanbaxy Merger On Hold
Mar 13, 2014 Sun Pharma Announces Import Alert for Karkhadi unit from US FDA
Mar 13, 2014 Import Alert for Karkhadi unit from US FDA